Beijing Airdoc Technology Co (HKSE:02251) Capex-to-Revenue : 0.11 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Beijing Airdoc Technology Co's Capital Expenditure for the six months ended in Dec. 2023 was HK$-14.42 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$132.85 Mil.

Hence, Beijing Airdoc Technology Co's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.11.

Beijing Airdoc Technology Co Capex-to-Revenue Historical Data

The historical data trend for Beijing Airdoc Technology Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Capex-to-Revenue Chart

Beijing Airdoc Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

0.06

0.46

0.24

0.11

0.08

Beijing Airdoc Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial				0.22	0.19	0.06	0.03	0.11

Competitive Comparison of Beijing Airdoc Technology Co's Capex-to-Revenue

For the Health Information Services subindustry, Beijing Airdoc Technology Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Airdoc Technology Co's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Beijing Airdoc Technology Co's Capex-to-Revenue falls into.

Beijing Airdoc Technology Co Capex-to-Revenue Calculation

Beijing Airdoc Technology Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-16.787)	/	223.092
	=	0.08

Beijing Airdoc Technology Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-14.424)	/	132.853
	=	0.11

Beijing Airdoc Technology Co (HKSE:02251) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Beijing Airdoc Technology Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Airdoc Technology Co (HKSE:02251) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN

Website

https://www.airdoc.com

Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.

Executives

Mialkos Tomasz Jakub	2101 Beneficial owner
Zhang Dalei	2501 Other
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd.	2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Chen Mingqiang	2501 Other
Gao Fei	2501 Other
Niagara Falls Holding Limited	2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines